In this editorial, I highlight the role of epidemiology as a dissense of the implications of advances in human genetics and cipline that provides population-based information on the rethe barrage of gene discoveries that hits us on a daily basis (see lationship between human genetic variation and various human the results of a recent World Wide Web search2 in Table I ). diseases. I also invite authors to submit the results of epidemiUnfortunately, what happens after a new gene discovery is ologic investigations to Genetics in Medicine, and thus, to conannounced is often a haphazard mixture of scientific excitetribute to translating advances in human genetics research into ment, heightened public awareness, and commercial interest in medical and public health practice.
developing and marketing genetic tests. This is exemplified in
GENE DISCOVERY AND THE RAPID TRANSITION TO MEDICAL PRACTICE
In the first issue of Genetics in Medicine, Dr. Richard King stated that the journal's vision is that genetics plays a central role in the practice of medicine through the prediction and prevention of disease and the promotion of public health.' In order to realize this vision, there is an urgent need to begin making Table 1 Selected headlines for news stories on genetics discoveries in USA Today Table 2 shows the accompanying news coverage of this event from one MrMrW ~o u r c e .~ Although this study needs further replication and its implications in medical practice are far from clear, it does illustrate the mounting pressures for a rapid transition from gene discovery to integration in clinical practice, which could result in the premature development and offering of genetic tests.
To ensure a systematic translation of genetic research into clinical practice, the National Institutes of Health Department of Energy Task Force on Genetic Testing recently released national recommendations on promoting safe and effective genetic testing in the United States, emphasizing the need for data throughout the translation pro~ess.~ Types of data on genetic tests include information on their analytic and clinical validity, clinical utility, as well as data on post-marketing surveillance of the impact Table 2 1997 news story: "Genetic Defect Doubles Colon Cancer RisY5
Researchers have found a new genetic defect present in one of every 17 h n e rican Jews that doubles a person's colon cancer risk. This mutation is now the most common cancer-associated gene defect identified in any ethnic population. Rarely present in non-Jews, the mutation appears to be responsible for about one in four cases of inherited colon cancer in Ashkenazi Jews-those of Eastern European ancestry who constitute more than 95 percent of America's six million Jewish people.
The good news is that scientists have developed a blood test, available for $200, that can detect this genetic defect. The test is advisable for everyone in the Ashkenazim population, whether they have a family history of colon cancer or not. A positive blood test can alert people to the need for regular colon examinations, called colonoscopies, which can detect colon cancer in its earliest stages when it is prevented or treated through removal of growths in the colon. This search was conducted on December 15,1998 
WHAT IS EPIDEMIOLOGY?
Epidemiology has been defined in many ways and is often viewed as the scientific core of public health.6 One widely used definition is "the study of the distribution and determinants of health-related states or events in populations, and the application of this study to control health problems."' Epidemiologists not only investigate outbreaks of disease in different populations but also conduct studies to determine risk factors for various diseases, identify sections of the population with highest risk in order to target prevention and intervention opportunities, and evaluate the effectiveness of health programs and services in improving the health of the p o p~l a t i o n .~ Over the last two decades, epidemiologic methods and approaches have been increasingly integrated with those of genetics in the discipline of genetic epidemiology, which seeks to find the role of genetic factors in disease occurrence in populations and fa mi lie^.^ On the other hand, a new brand of epidemiology has emerged; molecular epidemiology seeks to study the disease occurrence using biological markers of exposures, susceptibility, and effects.I0
Most discoveries for gene variants are based on studies of high-risk families or selected groups. To translate the results of this genetic research into opportunities for treating and preventing disease and promoting health, population-based epidemiologic studies are increasingly needed to quantify the impact of gene variants on the risk of disease, death, and disability and to identify and quantify the impact of modifiable risk factors that interact with gene variants. The results of such studies will help medical and public health professionals to better target medical, behavioral, and environmental interventions. Epidemiologic studies are also required in the process of clinical validation of new genetic tests, monitor population utilization of genetic tests, and determine the safety and effectiveness of genetic tests and services in different populations.
For this to be accomplished, there must be collaboration among epidemiologists, clinical geneticists, laboratory scientists, and medical and public health practitioners from government, professional, academic, industry, and consumer organizations. A combined genetic-epidemiologic approach is essential for a better understanding of disease etiology and development of molecular diagnostics. Data generated from such collaboration are urgently needed for the development of medical and public health policy. For example, issues are currently debated regarding population-based genetic testing for breast cancer in relation to BRCAl," for Alzheimer's disease in relation to the apolipoprotein E-E4 allele,12 and for iron overload in relation to the hemochromatosis gene.I3 Given the paucity of population-based epidemiologic data regarding the frequency of, and disease risks and environmental interactions for many newly discovered human gene variants, there is concern that appropriate health policy on the use of genetic tests may not be possible.
HUMAN GENOME EPIDEMIOLOGY (HUGE)
A global effort was recently launched by the Centers for Disease Control and Prevention and its many partners from the Human Genome Epidemiology Network (HuGE Net).'" HuGE Net seeks to promote global collaboration in the development and dissemination of peer-reviewed epidemiologic information on human genes, to develop an updated and accessible knowledge base on the World Wide Web, and to promote the use of this knowledge base by health care providers, researchers, industry, government, and the public for making decisions involving the use of genetic tests and services for disease prevention and health promotion. 14 The term human genome epidemiology (HuGE) denotes an evolving field of inquiry that uses systematic applications of epidemiologic methods and approaches in population-based studies of the impact of human genetic variation on health and disease. HuGE can be viewed as the intersection between genetic epidemiology and molecular epidemiology.'" Whereas genetic epidemiology has traditionally focused on techniques to find disease genes using linkage and segregation analysis, and molecular epidemiology focuses on using biological markers in epidemiologic studies, HuGE will begin to address issues related to the post-gene discovery phase. As 50,000 to 100,000 genes and their variants are yet to be discovered, the impact of such discoveries on epidemiologic research will be tremendous. As Shpilberg et a l l 5 simply put it, "The sequencing of the human genome offers the greatest opportunity for epidemiology since John Snow discovered the Broad Street pump," a reminder of Table 3 Categories and examples of Human Genome Epidemiolom studies Genetm m Medicine the contributions of epidemiology to controlling a cholera outbreak in London in the nineteenth century, long before the Vibrio organism was identified. The wide spectrum of topics addressed by investigators working on human genome epidemiology and selected examples are shown in Table 3 . The spectrum ranges from population-based epidemiologic research on gene variants to evaluation of genetic tests and services. Ultimately, HuGE represents the application of clinical and molecular research to a population setting and involves the collaboration and contribution of numerous specialties.
We would like to invite researchers to view Genetics in Medicine as a forum to share the results of genetic-epidemiologic investigations on human genome variation and its relation to disease. We also invite authors to collaborate in the Human Genome Epidemiology Network.
Selected results from accepted peer-reviewed articles will become part of the cumulative HuGE Net knowledge base on the World Wide Web according to criteria to be specified.22 Authors can also provide succinct HuGE reviews according to already specified g~i d e l i n e s .~~ Ultimately, these efforts will be crucial in translating advances in human genetics into population-based data for the practice of medicine in the new millennium.
